Cardiovascular System in Obesity: Effect of Treatment

• Status: Completed
• Trial end date: 1988-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the long-term efficacy of the combination therapy of phentermine and fenfluramine in conjunction with diet, exercise, and behavior modification in the treatment of simple, moderate obesity.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Fenfluramine; Phentermine

Criteria

Men and women, ages 18 to 60. Body weight was 130 to 180 percent of ideal body weight.